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ABSTRACT
Aim: This study estimated the diagnostic yield of oesophagogastroduodenoscopy (OGD) 
in young children with non-acute, non-specific gastrointestinal or respiratory symptoms 
who were treated by a Finnish tertiary level referral centre.
Methods: A retrospective chart analysis was performed on 1850 Finnish children under 
seven years of age who underwent their first diagnostic OGDs at Helsinki University 
Hospital during 2006-2016. We noted the endoscopy indications, macroscopic findings, 
the histology of the mucosal biopsies and the follow-up data.
Results: After the exclusion criteria were applied, we enrolled 666 patients (57.7% boys) 
at a median age of 3.5 years. The number of children with non-specific symptoms 
referred for OGD increased 2.3-fold in 11 years. A routine set of biopsies was obtained in 
644/666 (96.7%) of the endoscopies. The OGD was both macroscopically and 
histologically normal in 519/644 (80.6%) of cases. The most common indication was to 
rule out gastro-oesophageal reflux disease in 268/666 (40.2%) cases and the most 
frequent histological diagnosis was mild to moderate oesophagitis in 57/644 (8.9%) 
cases. There was no erosive oesophagitis.
Conclusion: The diagnostic yield of macroscopic and histological OGD findings was low 
in our cohort. Unless there are alarming symptoms, younger children do not need OGD.
Key words: Biopsy; Gastritis; Gastro-oesophageal reflux; Oesophagitis; Respiratory 
symptoms
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ABBREVIATIONS
FGID, Functional gastrointestinal disorder; GOR, Gastro-oesophageal reflux, GORD, 
Gastro-oesophageal reflux disease; GI, Gastrointestinal; IQR, interquartile range; OGD, 
oesophagogastroduodenoscopy
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  Key notes:  
-We estimated the diagnostic yield of the first oesophagogastroduodenoscopy (OGD) 
performed in 666 children under the age of seven with non-acute, non-specific 
gastrointestinal or respiratory symptoms.
-The number of children with non-specific symptoms referred for OGD increased 2.3-fold 
from 2006-2016, but the diagnostic yield of macroscopic and histological OGD findings 
was low in this Finnish cohort.
-Unless there are alarming symptoms, younger children do not need OGD.
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INTRODUCTION 
Upper endoscopy, or oesophagogastroduodenoscopy (OGD), is a 
convenient tool to diagnose and treat many diseases of the 
gastrointestinal (GI) tract (1). However, it is not easy to select 
patients for this procedure because GI symptoms are common and 
are poor in predicting the diagnostic yield of paediatric OGDs (2,3). 
In infancy, the most common functional gastrointestinal disorder 
(FGID) is gastro-oesophageal reflux (GOR) which is defined as the 
passage of gastric contents to the oesophagus and is often 
considered physiological (4-7). In children older than four years of 
age, the pain related FGIDs dominate (8-9).
Gastro-oesophageal reflux disease (GORD) is defined as a 
condition in which GOR provokes troublesome symptoms or 
complications such as oesophagitis (6, 7, 10, 11). The estimated 
prevalence of GORD has been shown to vary widely and increase 
with age (10).  In studies on paediatric GORD, oesophagitis 
diagnosed with OGD has mainly been found in children with 
structural abnormalities of the gastrointestinal (GI) tract and in 
children with neurodevelopmental abnormalities (12, 13). The role 
of OGD in the diagnosis of non-acute upper GI symptoms in 
otherwise healthy young children is less clear (2, 14, 15).
The role of GOR or GORD in causing asthma, wheezing or cough 
remains unproven (16-17). The suggestion that GORD causes 
respiratory symptoms is not supported by the European Society of 
Paediatric Gastroenterology and Nutrition position paper on GOR 
and GORD (18). However, during the last few decades various 
respiratory symptoms were linked to GORD and OGD is often 
performed together with a bronchoscopy. 
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The number of patients receiving OGD has risen rapidly in last two 
decades(2, 14, 19, 20, 21). Interestingly, most of the paediatric 
OGDs performed have been reported to yield a normal result (2, 3, 
15, 20, 21). These studies have addressed the whole paediatric 
population, from infancy through to the teenage years and have 
produced variable definitions for the normal OGD. Our own clinical 
experience suggests that the rate of fully normal OGDs is high 
among infants and young children with unknown predisposing 
factors. However, data on OGD findings in the youngest children 
are scarce. Therefore, the aim of this study was to evaluate the 
diagnostic yield of OGD in infants and children younger than seven 
years of age presenting with non-acute, non-specific GI and 
respiratory symptoms leading to the endoscopy. The study covered 
the first OGDs performed on patients from 2006-2016.
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METHOD
Study participants
We performed a retrospective chart review on all children younger 
than seven years of age who had undergone an OGD at Helsinki 
University Children’s Hospital, Finland, a tertiary level referral 
centre, between 2006-2016. Cases were identified by using the 
Nordic Classification code for Surgical Procedures UJD10 for upper 
endoscopy. Our centre performs nearly all paediatric endoscopies 
in the Uusimaa region of Finland, which has a population of 1.7 
million. The smaller hospitals mainly perform OGDs to diagnose 
antibody screening positive coeliac disease and the data from these 
centres were not included in this study.
We identified 2750 OGDs, but only included the first diagnostic 
OGD per patient and this provided 1850 cases. The medical 
diagnoses were listed according to the International Classification of 
Diseases codes version 10. We excluded patients with pre-
diagnosed malformations of the GI tract, upper airway and head or 
neck area, as well as patients with short bowel syndrome, portal 
hypertension, known oesophageal varices or acute hematemesis 
and graft versus host disease. The exclusion criteria also included 
OGDs performed to place a gastrostomy, cases with suspected 
antibody screening positive coeliac disease and patients who 
underwent OGD to obtain Helicobacter pylori -cultures or identify a 
foreign body or caustic injury (Figure 1). 
The final number of children with primary OGDs was 666 and they 
were placed in two groups. The first was non-specific non-acute 
gastrointestinal symptoms such as abdominal pain, vomiting, 
regurgitation, heartburn, dysphagia and feeding problems with 
failure to thrive. The second was common respiratory symptoms 
such as prolonged coughing, wheezing, poor response to asthma A
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medication and recurrent pneumonia. We collected data on patient 
demographics, such as gestational age at birth, previous diagnoses 
and medication.
We categorised the patients as follows: 122 (60.7% male) were up 
to one year of age, 230 (64.8% male) were 1-2 years of age and 
314 (51.3% male) were 3-6 years of age. We used the leading 
symptom for analysis if several symptoms were listed. 
Upper endoscopy
All OGDs were performed by paediatric surgeons and paediatric 
gastroenterologists under general anaesthesia, using propofol 
maintenance and video endoscopes that were appropriate for the 
patient’s age and size. Biopsies were taken from the duodenum, the 
antrum, the corpus, and the oesophagus, even if the macroscopic 
appearance was normal. The biopsies were investigated by small 
number of paediatric pathologists who graded the level of 
inflammation as none, mild, moderate or severe according to the 
presence of inflammatory changes.  The histological diagnoses 
were not re-assessed.
We noted the macroscopic endoscopy findings and the 
histological diagnoses from the obtained biopsies. If the patient also 
underwent a bronchoscopy or a colonoscopy, we also reviewed the 
histological diagnosis from those biopsies. The clinical impact of the 
OGD on patient’s consecutive care was judged to be positive if the 
OGD results confirmed a new diagnosis or changed the medical 
treatment and, or the follow-up plan. We reviewed all the OGD-
related complications and any symptoms that led to contact with the 
hospital within 72 hours after the OGD. 
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Each patient’s medical chart was reviewed until 15 March 2018. 
The Helsinki University Hospital Ethics committee approved this 
study (HUS/3668/2017). According to Finnish legislation, informed 
consent was not needed for this register-based study. 
Statistical methods
Data are provided as medians and interquartile ranges (IQR) unless 
otherwise stated. Comparisons between the OGD findings in the 
age groups and between patients with or without acid blockers at 
the time of the OGD were analysed using Fisher’s exact test. The 
software used was GraphPad Prism version 7.01 for Windows, 
(GraphPad Software, San Diego, California USA). Statistical 
significance was set as p<0.05.
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RESULTS
Patients 
We identified 666 children (57.7% male) who had undergone their 
first diagnostic OGD because of non-acute non-specific 
gastrointestinal or respiratory symptoms at less than seven years of 
age (Table 1). More than 90% were Caucasian and their median 
age was 3.5 years (IQR 1.5-5.2).  The number of OGDs in our 
cohort increased 2.3-fold during the 11-year study period due to the 
increased number of patients with respiratory or reflux-related 
symptoms referred to an OGD (Figure 2). Of the 666 children, more 
than one-third (n=267, 40.1%) had been diagnosed with a chronic 
condition such as asthma and, or, atopy (n=100,15.0%), or food 
allergies with gastrointestinal symptoms (n=26, 3.9%). Functional 
gastrointestinal disorders were noted in 47 (7.6%). Other non-GI 
conditions among the 666 children were congenital syndromes and 
non-GI malformations (n=75, 11.3%), epilepsy or neurologic 
impairment including cerebral palsy (CP) (n=23, 3.5%). Data on 
pregnancy and birth were available for 477 (71.6%) of the 666 
children, and 100/477 (54.0% boys) were born prematurely before 
37 weeks of gestation. 
Nearly 30% of the 666 patients had at least one previous 
prescription of acid blockers (>95% proton pump inhibitors) and 598 
(89.8%) of patients had a minimum of two weeks free from acid 
blockers prior to the OGD. Despite being advised to stop the acid 
blockers before the OGD, 42 (6.3%) continued to be given them 
due to perceived GORD symptoms and there were no data for the 
other 26 (3.9%). 
Symptoms and endoscopy indications
The most commonly reported symptoms resulting in an OGD were 
reflux related, such as dysphagia, spitting up or vomiting, heartburn, A
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problems with eating in 236/666 (35.4%) cases. The number of 
patients with various respiratory symptoms such as wheezing, 
rhonchi, cough and recurrent pneumonias was 136/666 (20.4%) 
and haematochezia was 115/666 (17.2%). The three most frequent 
clinical indications for the OGD were suspicion or exclusion of 
GORD in 268/666 (40.2%) cases, differential diagnosis of non-
specific respiratory symptoms in 120/666 (18.0%) and inflammatory 
bowel disease in 107/666 (16.1%).
Endoscopy findings
Macroscopic appearance was normal in 94.0% of subjects (Table 
2). The most common macroscopic abnormality that was reported 
was dull oesophageal mucosa without erosions (27.5%). Routine 
biopsies were taken in 96.7% of cases. The median age of 22 
patients (68.2% male) who were not biopsied was 2.8 years (IQR 
0.5 -5.1) and the macroscopic appearance was considered normal 
in 20. Of the remaining two patients, one had a suspicion of 
malrotation and the other had dull oesophageal mucosa. Of the 
patients with macroscopic abnormalities, 24/40 (60.0%) had 
histological changes.
We found no significant difference in the macroscopic findings 
between the age groups. 
The most frequent histological diagnosis was oesophagitis in 
57/644 (8.9%) cases, of which 78.9% were classified as mild and 
21.1% as moderate. None had severe erosive oesophagitis. Of the 
cases with oesophagitis, 41/57 (71.9%) were diagnosed with clinical 
GORD, which presented 6.4% of all OGDs, Tables 2, 3 and 4. The 
occurrence of GORD-related histological oesophagitis increased 
with age: one histological oesophagitis in a patient younger than 
one year of age and 23 in patients aged 3-6 years of age (p=0.017). A
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One-third of the children with histological reflux oesophagitis had a 
non-GI congenital malformation or a neurologic debilitating 
diagnosis. The incidence of GORD-related histological oesophagitis 
in children with cerebral palsy was 40.0% (4/10) and 13.0% 
(13/100) in the group of children born prematurely. Only one patient 
with respiratory symptoms had macroscopic changes (0.8%) and 
mild histological oesophagitis was found in 8/115 (7.0%) including 
five patients without OGD biopsies, Table 3.  
 Eosinophilic oesophagitis was found in two boys (0.3%) while 
oesophagitis, caused by Candida albicans-infection and gastric 
metaplasia in the oesophagus, were each found in one patient. 
(Table 4). The frequency of histological findings rose with increasing 
age (Table 2). The data on acid blocker use was available for all 
patients with histological oesophagitis and for 252/268 (94.0%) with 
a suspicion of GORD. Of those with suspected GORD who 
continued to be given the acid blockers, 14.0% had histological 
oesophagitis compared with 17.7% of patients without an acid 
blocker (p=0.82). 
After oesophagitis, the second most common abnormal histological 
finding was gastritis in 28/644 (4.3%) cases. Most of the gastritis 
cases were mild or superficial (25/28, 89%), and half of them were 
found with concurrently diagnosed inflammatory bowel disease 
(Tables 2, 3 and 4). 
We found a few cases of duodenitis, including one severe 
eosinophilic enteritis (Table 4). There were no cases with villous 
atrophy compatible with undiagnosed coeliac disease. Likewise, 
there were no unexpected cases of Helicobacter pylori colonisation.
The OGD result was macroscopically and histologically normal in 
519/644 (80.6%) of the patients. The macroscopic and, or 
histological results only had a positive impact on the patient’s A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved
consecutive care in 70/666 (10.5%) patients. They included 43 
children with newly diagnosed inflammatory bowel disease.
Anaesthesia and, or OGD related complications were rare. One 
patient, aged one year, was admitted to intensive care because of 
respiratory distress related to airway obstruction after extubation. 
We found three cases of post-operative fever and two cases of 
prolonged wheezing and urticaria.
The median length of follow-up was two years (IQR 0.5 -5) and we 
lost only 16/666 patients (2.4%) to follow-up. There were no 
clinically significant changes in patients’ diagnoses during the 
follow-up period.
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DISCUSSION
 
We conducted a retrospective chart review of 666 children who 
were younger than seven years of age and had undergone an 
upper GI endoscopy -oesophagogastroduodenoscopy or OGD- to 
diagnose non-specific GI and, or respiratory symptoms. All had 
been admitted to our tertiary level children's hospital between 2006 
and 2016. Our referral centre in Helsinki, Finland, is the largest in 
the country and serves a population of 1.7 million inhabitants, 
including approximately 200,000 children younger than seven years 
of age. Our aim was to describe the diagnostic yield of the OGD 
findings in this young patient group with non-specific symptom 
profiles.
In our study, the number of fully normal OGDs was high (80.6%). 
This number was in line with those reported by the previous studies 
(2, 3, 15, 21, 22, 23) with older cohorts. In our cohort, the OGD 
yielded novel information in only 10.5% of cases. The macroscopic 
appearance was normal in nearly all patients in our cohort (94.0%). 
The few macroscopic findings noted were related to the appearance 
of oesophageal mucosa. The prevalence of erosive oesophagitis is 
known to raise with age (23). Our findings were in line with this, as 
there were no cases of erosive oesophagitis in our cohort of 
children who were younger than seven years of age. The most 
common histological diagnosis was mild to moderate oesophagitis 
(8.9%), and only 18.0% of these cases were related to non-specific 
macroscopic mucosal changes. We found that 70.2% of the cases 
with histological oesophagitis occurred in patients with clinical 
GORD. The significance of non-erosive histological oesophagitis in 
GORD is unclear (24). Non-erosive reflux oesophageal phenotypes 
were assessed in a study of children who were over five years of 
age (25), but studies addressing younger children have been under-A
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powered due very small numbers of patients. Our results indicate 
that histological findings, suggesting a disease pathology, are rare 
in infants with non-specific symptoms.
In the present study, the most common indication for an OGD was 
the need to confirm suspected GORD or exclude it. The correlation 
of GOR-related symptoms and positive OGD findings in children 
has previously been shown to be poor (2, 3, 22, 23, 26). Our results 
were in line with this. European Society of Paediatric 
Gastroenterology, Hepatology and Nutrition published a position 
paper on GORD in 2018 stating that OGD was not recommended 
for first line diagnostics. However, the paper did state that it could 
be used to  evaluate alarming symptoms and possible 
complications of GORD and in differential diagnostics (18). Other 
guidelines are also available (19). Our data should reassure 
clinicians to treat reflux symptoms according to expert guidelines, 
as erosive oesophagitis is extremely rare in non-syndromic infants 
with non-specific symptoms. 
The incidence of paediatric eosinophilic oesophagitis has been 
increasing in both North America and Europe (27), but it has only 
just started to rise in Finland. Our two patients with histologically 
confirmed eosinophilic oesophagitis had significant symptoms 
leading to weight loss, but the suspicion was not confirmed in those 
with less severe symptoms.  Because we routinely biopsy even 
macroscopically normal mucosa, it is unlikely we would have 
missed cases of eosinophilic oesophagitis.
Various respiratory symptoms may cause a suspicion of GORD or 
structural abnormalities and OGD is often performed in addition to a 
bronchoscopy. The role of GORD and so-called silent GORD in A
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causing respiratory symptoms or asthma has not been proven (16, 
17). A review published in 2018 stated that the data suggested that 
GORD did not cause or result from asthma (28). In our study, 
respiratory symptoms were not associated with significant 
macroscopic or histological OGD findings. 
Gastritis was rare in our patients and was found in patients 
diagnosed with inflammatory bowel disease. In our study, those with 
known positive coeliac disease serology were excluded and there 
were no incidental cases of villous atrophy. 
Our results suggest that, in order to gain best diagnostic yield, the 
referral criteria for OGD must be clearly stated. The decision to 
perform an OGD should be based on the objective criteria in the 
current international recommendations (18, 19).  
A strength of this study was the uniformity of the single centre-
based data, with a large number of patients. The OGDs were 
performed by experienced paediatric surgeons and paediatric 
gastroenterologists. OGD performed under general anaesthesia 
was safe in this cohort, with less than 1% experiencing post-
operative medical problems. This rate was smaller than the rates 
presented in previous studies (29, 30).  
Nearly all patients had routine biopsies taken and the histological 
analyses were conducted by a small number of paediatric 
pathologists. Since health care in Finland is government-funded, 
our comprehensive cohort comprised children from all 
socioeconomic groups. 
The limitations of this study, as in most retrospective studies, 
included the fact that medical charts were not always complete. 
Also, our study cohort was comprised almost entirely of Caucasians A
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with an urban background. Although parents were advised to 
discontinue the use of acid blockers prior to their child having an 
OGD, a small number were still given the medication.  This may 
have affected the grade of histological oesophagitis. However, 
those who continued to medicate their children were doing so 
because of ongoing perceived, severe GORD-related symptoms 
and therefore any erosive oesophagitis underlying these symptoms 
would have been noted. 
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CONCLUSION
The diagnostic yield of OGD was low in our cohort of 666 infants 
and young children who were younger than seven years of age and 
presented with non-specific, non-acute symptoms. We believe that 
younger children do not need OGDs unless they present with 
alarming symptoms.
FUNDING SOURCE:  This study did not receive any specific funding. 
 
CONFLICTS OF INTEREST: The authors have no conflicts of interest to declare.
 
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved
References
1. Friedt M, Welsch S. An update on pediatric endoscopy. Eur J Med Res. 2013 Jul 
25;18:24,783X-18-24.
2. Alabd Alrazzak B, Husien T, Preston DL, Elitsur Y. Upper endoscopy in children: Do 
symptoms predict positive findings? Clin Pediatr (Phila). 2014 May;53(5):474-8.
3.Wang S, Younus O, Rawat D, Naik S, Giles E, Meadows N et al.  Clinical Presentation 
and Outcomes of Diagnostic Endoscopy in Newly Presenting Children With 
Gastrointestinal Symptoms. J Pediatr Gastroenterol Nutr: June 2018 - Volume 66 - Issue 
6 - p 876–881
4. Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence of symptoms of 
gastroesophageal reflux during childhood: A pediatric practice-based survey. pediatric 
practice research group. Arch Pediatr Adolesc Med. 2000 Feb;154(2):150-4.
5. Lightdale JR, Gremse DA, Section on Gastroenterology, Hepatology, and Nutrition. 
Gastroesophageal reflux: Management guidance for the pediatrician. Pediatrics. 2013 
May;131(5):e1684-95.
 6. Rybak A, Pesce M, Thapar N, Borrelli O. Gastro-esophageal reflux in children. Int J 
Mol Sci. 2017 Aug 1;18(8):10.3390/ijms18081671.
7. Benninga MA, Faure C, Hyman PE, St James Roberts I, Schechter NL, Nurko S. 
Childhood functional gastrointestinal disorders: Neonate/toddler. Gastroenterology 
Volume 150, Issue 6, May 2016, Pages 1443-1455.e2
8. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal 
pain in western countries: A systematic review. Am J Gastroenterol. 2005 
Aug;100(8):1868-75.
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved
9. Boronat AC, Ferreira-Maia AP, Matijasevich A, Wang YP. Epidemiology of functional 
gastrointestinal disorders in children and adolescents: A systematic review. World J 
Gastroenterol. 2017 Jun 7;23(21):3915-27.
10. Mousa H, Hassan M. Gastroesophageal reflux disease. Pediatr Clin North Am. 2017 
Jun;64(3):487-505.
11. Gold BD. Review article: Epidemiology and management of gastro-oesophageal 
reflux in children. Aliment Pharmacol Ther. 2004 Feb;19 Suppl 1:22-7.
12. Kim S, Koh H, Lee JS. Gastroesophageal reflux in neurologically impaired children: 
What are the risk factors? Gut Liver. 2017 Mar 15;11(2):232-6.
13. Marseglia L, Manti S, D'Angelo G, Gitto E, Salpietro C, Centorrino A, et al. 
Gastroesophageal reflux and congenital gastrointestinal malformations. World J 
Gastroenterol. 2015 Jul 28;21(28):8508-15.
14. Volonaki E, Sebire N, Borrelli O, Lindley K, Elawad M, Thapar N, et al. 
Gastrointestinal endoscopy and mucosal biopsy in the first year of life: indications and 
outcome. J.Pediatr.Gastroenterol.Nutr., 2012, 55, 1, 62-65
15. Bonilla S, Deli W, Saps M. The prognostic value of obtaining a negative endoscopy in 
children with functional gastrointestinal disorders. Clin Pediatr (Phila). 2011 
May;50(5):396-401.
16. Sopo SM, Radzik D, Calvani M. Does treatment with proton pump inhibitors for 
gastroesophageal reflux disease (GERD) improve asthma symptoms in children with 
asthma and GERD? A systematic review. J Investig Allergol Clin Immunol. 2009;19(1):1-
5.
17. Blake K, Teague WG. Gastroesophageal reflux disease and childhood asthma. Curr 
Opin Pulm Med. 2013 Jan;19(1):24-9.
18. Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, et al. 
Pediatric gastroesophageal reflux clinical practice guidelines: Joint recommendations of A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved
the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and 
the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr 
Gastroenterol Nutr. 2018 Mar;66(3):516-54.
19. Lightdale J, Acosta R, Shergill A, Chandrasekhara V, Chathadi K, Early D et al ASGE 
Standards of Practice Committee. Modifications in endoscopic practice for pediatric 
patients Gastrointest.Endosc., 2014, 79, 5, 699-710
20. Franciosi JP, Fiorino K, Ruchelli E, Shults J, Spergel J, Liacouras CA, et al. Changing 
indications for upper endoscopy in children during a 20-year period. J Pediatr 
Gastroenterol Nutr. 2010 Oct;51(4):443-7.
21. Thomson M, Sharma S. Diagnostic yield of upper and lower gastrointestinal 
endoscopies in children in a tertiary centre. J Pediatr Gastroenterol Nutr 2017 
Jun;64(6):903-906
22. Gupta SK, Hassall E, Chiu YL, Amer F, Heyman MB. Presenting symptoms of 
nonerosive and erosive esophagitis in pediatric patients. Dig Dis Sci. 2006 
May;51(5):858-63.
23. Gilger MA, El-Serag HB, Gold BD, Dietrich CL, Tsou V, McDuffie A, et al. Prevalence 
of endoscopic findings of erosive esophagitis in children: A population-based study. J 
Pediatr Gastroenterol Nutr. 2008 Aug;47(2):141-6.
 24.Gonzalez Ayerbe JI, Hauser B, Salvatore S, Vandenplas Y. Diagnosis and 
Management of Gastroesophageal Reflux Disease in Infants and Children: from 
Guidelines to Clinical Practice. Pediatr Gastroenterol Hepatol Nutr. 2019;22(2):107–121. 
25. Mahoney L, Nurko S, Rosen R. The Prevalence of Rome IV Nonerosive Esophageal 
Phenotypes in Children. J.Pediatr., Oct 2017, vol 189, 86-91
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved
26.Sheiko MA, Feinstein JA, Capocelli KE, Kramer RE. Diagnostic yield of EGD in 
children: a retrospective single-center study of 1000 cases. Gastrointest.Endosc., 2013, 
78, 1, 47-54.e1
27. Arias Á, Pérez‐Martínez I, Tenías JM, Lucendo AJ. Systematic review with 
meta‐analysis: the incidence and prevalence of eosinophilic oesophagitis in children and 
adults in population‐based studies. Aliment Pharmacol Ther, 2016,43: 3-15
28. de Benedictis FM, Bush A. Respiratory manifestations of gastro-oesophageal reflux in 
children. Arch Dis Child 2018;103:292-6
29. Kramer RE, Narkewicz MR. Adverse events following gastrointestinal endoscopy in 
children: Classifications, characterizations, and implications. J Pediatr Gastroenterol Nutr. 
2016 Jun;62(6):828-33.
30. Thakkar K, El-Serag HB, Mattek N, Gilger MA. Complications of pediatric EGD: A 4-
year experience in PEDS-CORI. Gastrointest Endosc. 2007 Feb;65(2):213-21.
 
A
cc
ep
te
d
 A
rt
ic
le
 This article is protected by copyright. All rights reserved 
Table 1 
Background data on the study cohort of 666 paediatric patients younger than seven years of 
age, median age 3.5 years (IQR 1.5 -5.2), who underwent oesophagogastroduodenoscopy 
(OGD) because of unspecific gastrointestinal or common respiratory symptoms. Single centre 
data from years 2006-2016. 
 Age 0-1 year Age 1-3 years Age 3-6 years 
Number of patients 122 230 314 
Gender male/ % 74/ 60.7% 149/ 64.8% 161/ 51.3 % 
Indication for OGD 
(number/% of all in 
each age group): 
   
Suspicion of GORD  
n=268 
38/ 31.1% 
 
100/ 43.5% 
 
130/ 41.4% 
 
Common respiratory 
symptoms n=120 
41/ 33.6% 59/ 25.7% 20/ 6.4% 
Suspicion of IBD n=107 2/ 1.6% 
 
25/ 10.9% 
 
80/ 25.5% 
 
Hematochezia (non-
IBD) n=50 
6/ 4.9% 13/5.7% 31/9.9% 
Exclusion of anatomic 
abnormality n=33 
24/ 19.7% 4/ 1.7% 5/ 1.6% 
 
Dysphagia n=16 0 4/ 1.7% 12/ 3.8% 
Failure to thrive n=15 6/ 4.9% 8/ 3.5% 1/0.3% 
Anemia n=8 0 0 8/ 2.5% 
Malabsorption/diarrhea 
n=8 
2/1.6% 
 
2/0.9% 
 
4/1.3% 
 
Recurrent abdominal 
pain n=7 
0 0 7/ 2.2% 
Suspicion of EoE n=7 0 3/1.3% 4/ 1.3% 
Protein-losing 
enteropathy n=5 
3/ 2.5% 
 
2/ 0.9% 
 
0 
 
Suspicion of 
mastocytosis n=5 
0 3/1.3% 2/ 0.6% A
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Othera n=13 0 4/1.7% 9/ 2.9% 
 EoE=eosinophilic esophagitis; GORD=gastro-oesophageal reflux disease; 
IBD=inflammatory bowel disease; IQR=interquartile range 
aincludes single patients with diverse indications 
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Table 2 
Data on endoscopy findings in the study cohort of 666 paediatric patients younger than seven 
years (y) of age (median age 3.5 y IQR 1.5 -5.2 y) who underwent 
oesophagogastroduodenoscopy (OGD) because of unspecific gastrointestinal or common 
respiratory symptoms. Single centre data from years 2006 -2016. 
 
Patient group Number of patients with 
positive macroscopic 
findings (%) 
Number of patients with 
positive histological 
findings (%) 
All 0-6 
n=666 
40/666(6.0%) 72/644a (11.2%) 
Up to 1 y 
(n=122) 
6/122 (4.9%) 8/104(7.7%) 
1-2 y (n=230) 13/230 (5.7%) 28/229 (12.2%) 
3-6 y (n=314) 21/314 (6.7%) 36/311 (11.5%) 
a22 patients without routine biopsies, only macroscopic evaluation available (18 patients in 
the 0-1y group, one in the group 1-3y and three in the group 3-6y)  
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Table 3 
Data on the relationship between indications and positive upper endoscopy findings in the 
study cohort of 666 paediatric patients younger than seven years (y) of age (median age 3.5 y, 
IQR 1.5-5.2) who underwent oesophagogastroduodenoscopy (OGD) because of unspecific 
gastrointestinal or common respiratory symptoms. Single centre data from years 2006-2016. 
The histological diagnosis was available for 644 patients (96.7%).  
 
Indication Number (n) of patients with positive 
macroscopic findings (%) 
Number (n) of patients with 
positive histological findings 
(%) 
Suspicion of GORD 
n=268  
median age 2.8 y   
(IQR 1.3-4.9) 
n= 11/268 (4.1%)  
median age 4.3 y (IQR 2.7-5.7) 
 
n=44/264a (16.7%)  
median age 3.7 y (IQR 2-5.8) 
 
Common respiratory 
symptoms n=120 
median age 3.5 y  
(IQR 1.8-5.2) 
n=1/120 (0.7%) 
 
n=8/115b (7.0%) 
median age 3.2 y (IQR 1.7-5.8) 
 
Suspicion of IBD n=107 
median age 3.6 y  
(IQR 1.9-5.3) 
n=6/107 (5.6%) 
median age 5.1 y (IQR 4.3-5.8) 
n=27/107 (25.2%) 
median age 4.3 y (IQR 3.4-5.7) 
Hematochezia (non-
IBD) n=50 
median age 3.5 y  
(IQR 1.7-5.3) 
n= 2/50 (4%) 
 
n= 11/47c (23.4%) 
median age 3.5 y (IQR 3.1-4.8) 
 
Exclusion of anatomic 
abnormalityd n=33 
median age 0.3y  
(IQR 0.06-1.4) 
n=2/33 (6.0%) 
 
n=1/24e (4.2%) 
 
Dysphagia n= 16 
median age 4.1 y  
(IQR 2.7-5.9) 
n=2/16 (12.5%) 
 
n=1/16 (6.3%) 
 
Failure to thrive n= 15 n=0 n=1/14f (7.1%) A
cc
ep
te
d
 A
rt
ic
le
 This article is protected by copyright. All rights reserved 
median age 1.2 y  
(IQR 0.6-1.8) 
 
Anemia n=8 
median age 4 y  
(IQR 2.2-5.7) 
n=0 
 
n=2/8 (25%) 
 
Malabsorption/diarrhea 
n=8 
n=1/8 (13%) n=2/8 (25%) 
Recurrent abdominal 
pain n=7 median age 
5.0 y (IQR 3-6.5) 
n=0 n=0 
Suspicion of EoE n=7 n=1/7 (14.3%)  n=1/7 (14.3%)  
Protein-losing 
enteropathy n=5 
n=2/5 (40%) n=2/5 (40%) 
Suspicion of 
mastocytosis n= 5  
median age 2 y  
(IQR 1.3-4.8) 
n=0 n=0 
Otherg n=13 
median age 4.2 y  
(IQR 1.8-5.6) 
n=4/13 (30.8%) n=9/13 (69.2%) 
 
EoE=eosinophilic esophagitis; GORD=gastro-oesophageal reflux disease; IBD=inflammatory 
bowel disease; IQR=interquartile range 
 
afour patients without histological evaluation 
bfive patients without histological evaluation 
cthree patients without histological evaluation 
dPatients with malformations of upper airway, head and neck area or the gastrointestinal tract 
excluded in the patient selection and are not included in this study 
enine patients without histological evaluation 
fone patient without histological evaluation 
gincludes single patients with diverse indications A
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Table 4  
Summary of histological diagnoses obtained from children younger than seven years of age 
(n=644) during upper endoscopy (oesophagogastroduodenoscopy, OGD)a. Endoscopies 
included routine biopsies from the duodenum, the corpus, the antrum and the esophagus. 
Single centre data from years 2006-2016.  
 
a)Oesophagitis  
 
Histological diagnosis  
  
Number (n, %)  Macroscopic appearance 
abnormal (n, %)  
Mild oesophagitis   
Up to 1year  
1-2 years  
3-6 years  
n=43/644 (6.7%)  
n=2 
n=17 
n=24 
n=4 
Moderate oesophagitis  
Up to 1 year  
1-2 years  
3-6 years  
n=9/644 (1.4%)  
n=0   
n=4  
n=5  
n=4 
Erosive/severe oesophagitis  n=0  n=0  
Eosinophilic oesophagitis  
Up to 1 year  
1-2 years  
3-6 years  
n=2 /644 (0.3%)  
n=0  
n=1  
n=1  
n=1 
Candida albicans 
oesophagitis  
n=1 /644 (0.2%)  
(age 6.4 years)  
n=1 
Mild oesophagitis and mild 
gastritis 
n=2/644 (0.3%) n=0 
Moderate oesophagitis and 
mild gastritis  
Up to 1 year  
1-2 years  
3-6 years  
n=3 /644 (0.3%)  
  
n=1 
n=1  
n=1 
n=1 
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Gastric metaplasia  n=1 /644 (0.2%)  
(age 1.7 years)  
n=1 
aThe total number of patients was 666 (22 patients without routine biopsies: 18 patients in the 
up to 1y group, one in the group 1-2y and three in the group 3-6y)  
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b)Gastritis  
 
Histological diagnosis  
  
Number (n, %)   Macroscopic appearance 
abnormal n (%)  
Mild/superficial gastritis  
Up to 1 year  
1-2 years  
3-6 years  
n=12/644a (1.9%)  
n=3   
n=2  
n=7  
n=0 
Gastritis associated with 
concurrently diagnosed 
inflammatory bowel disease  
Up to 1 year  
1-2 years  
3-6 years  
n=13/644 (2.0%)  
  
  
n=0  
n=2  
n=11  
n=1  
Moderate gastritis  
Up to 1 year  
1-2 years  
3-6 years  
n=2/644 (0.3%)  
n=0  
n=0  
n=2  
n=1 
Eosinophilic gastritis   
Up to 1 year  
1-2 years  
3-6 years  
n=2/644 (0.3%)  
n=0  
n=0  
n=2  
n=0  
Collagenous gastritis  
Up to 1 year  
1-2 years  
3-6 years  
n=1/644(0.2%)  
n=0 
n=0 
n=1 (age 5.8 years) 
n=1 
  
a
 The total number of patients was 666 (22 patients without routine biopsies: 18 patients in 
the up to 1y group, one in the group 1-2y and three in the group 3-6y)   
  
A
cc
ep
te
d
 A
rt
ic
le
 This article is protected by copyright. All rights reserved 
c)Duodenitis  
 
Histological diagnosis  Number (n, %) Macroscopic appearance 
abnormal n (%)  
Duodenitis with concurrent 
oesophagitis  
Up to 1 year  
1-2 years  
3-6 years   
n=1/644a (0.2%)  
  
n=1 (age 0.8 years) 
n=0 
n=0 
n=0  
Severe duodenitis with severe 
gastritis   
Up to 1 year  
1-2 years  
3-6 years  
n=1/644 (0.2%)  
 
n=1 (age 0.2 years) 
n=0 
n=0 
n=1 
Eosinophilic enteritis 
including eosinophilic 
oesophagitis, gastritis and 
duodenitis  
Up to 1 year  
1-2 years  
3-6 years   
n=1/644 (0.2%) 
 
 
n=0 
n=1 (age 2.4 years) 
n=0 
n=1 
a
 The total number of patients was 666 (22 patients without routine biopsies: 18 patients in 
the up to 1y group, one in the group 1-2y and three in the group 3-6y) 
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All OGDs performed to children under 7 years of age during years 2006-2016 
n=2750 
 
 
Included only the first OGD 
per patient n=1850 
 
Patients with short bowel 
disease or graft versus 
host disease n=50 
 
 
Patients with suspicion 
of coeliac disease n=271 
OGDs performed to place a 
gastrostomy n=214 
 
 
Patients with suspicion of 
foreign body or caustic injury 
in the oesophagus n=130
 
Patients with portal 
hypertension, known 
oesophageal varices or 
acute haematemesis 
n=43 
Patients with congenital 
malformations of upper 
respiratory, head and neck area 
or gastrointestinal tract n=462
 
 
Patients with pre- 
diagnosed Helicobacter 
pylori –infection n=14 
 
 
The number of first diagnostic OGDs in children with non-
acute unspecific gastrointestinal or common respiratory 
symptoms n=666 
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Figure 2 
Data on number of oesophagogastroduodenoscopy (OGD) in a single tertiary level children’s hospital during 
years 2006-2016. 
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